Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Taysha Gene Therapies, Inc. | 113,246 | reported | 02 Jun 2025 | tx 8+415,729 |
| Intellia Therapeutics, Inc. | 77,388 | reported | 03 Jan 2025 | tx 49+732,835−282,759 |
| Lexeo Therapeutics, Inc. | 50,000 | reported | 28 Apr 2026 | tx 1+50,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 21,335 | 0.00 USD | |
| 01 Jun 2026 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 42,671 | 0.00 USD | deriv |
| 28 Apr 2026 | GRANT_AWARD | Lexeo Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 02 Jun 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 56,623 | 0.00 USD | |
| 02 Jun 2025 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 113,246 | 0.00 USD | deriv |
| 03 Jan 2025 | SALE | Intellia Therapeutics, Inc. | 8,966 | 12.18 USD | |
| 01 Jan 2025 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | — | |
| 01 Jan 2025 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 49,220 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 98,440 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 37,966 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 54,794 | 0.00 USD | deriv |
| 08 Jan 2024 | SALE | Intellia Therapeutics, Inc. | 667 | 29.38 USD | |
| 08 Jan 2024 | SALE | Intellia Therapeutics, Inc. | 1,608 | 28.66 USD | |
| 03 Jan 2024 | SALE | Intellia Therapeutics, Inc. | 5,532 | 29.46 USD | |
| 01 Jan 2024 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | — | |
| 01 Jan 2024 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Taysha Gene Therapies, Inc. | 36,200 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 29,938 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Intellia Therapeutics, Inc. | 42,302 | 0.00 USD | deriv |
| 04 Jan 2023 | SALE | Intellia Therapeutics, Inc. | 2,508 | 37.21 USD | |
| 05 Jan 2023 | SALE | Intellia Therapeutics, Inc. | 1,641 | 38.22 USD | |
| 05 Jan 2023 | SALE | Intellia Therapeutics, Inc. | 689 | 39.10 USD | |
| 01 Jan 2023 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | — | |
| 01 Jan 2023 | EXERCISE | Intellia Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |